Ph 2 Prostate Cancer Results Strong Safety and 40% Response
Released
Latest announcements
Ask a question
Your question will be sent privately to Invion. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Invion a question about this announcement.